Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 65,456,657
- Total 13F shares
- 4,173,854
- Share change
- -122,109
- Total reported value
- $14,111,189
- Price per share
- $3.38
- Number of holders
- 19
- Value change
- -$864,475
- Number of buys
- 10
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 29446K106?
CUSIP 29446K106 identifies EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29446K106:
Top shareholders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
3.2%
|
2,069,233
|
$7,863,000 | — | 30 Sep 2019 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.6%
|
1,064,979
|
$4,047,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
0.95%
|
619,843
|
$2,355,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.43%
|
279,329
|
$1,062,000 | — | 30 Sep 2019 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.22%
|
141,260
|
$537,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
54,502
|
$207,000 | — | 30 Sep 2019 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.04%
|
24,090
|
$91,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
15,869
|
$61,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
9,425
|
$36,000 | — | 30 Sep 2019 | |
| Edge Wealth Management LLC |
13F
|
Company |
0.01%
|
7,072
|
$26,000 | — | 30 Sep 2019 | |
| Partner Investment Management, L.P. |
13F
|
Company |
0.01%
|
5,333
|
$20,000 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,167
|
$12,000 | — | 30 Sep 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 30 Sep 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
682
|
$2,592 | — | 30 Sep 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
582
|
$2,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
463
|
$2,000 | — | 30 Sep 2019 | |
| CWM, LLC |
13F
|
Company |
0%
|
300
|
$2,000 | — | 30 Sep 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
223
|
$1,000 | — | 30 Sep 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
189
|
$1,000 | — | 30 Sep 2019 |
Institutional Holders of Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) as of Q4 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.